Dermatotoxicology: Historical perspective and advances

Toxicology and Applied Pharmacology

Volumn 243, Issue 2, 2010, Pages 225-238

  Ngo, Mai A ^a   Maibach, Howard I ^b  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADME; Dermatitis; in vitro; QSAR; Regulatory; Transdermal

Indexed keywords

CHEMICAL AGENT;

CONTACT DERMATITIS; CONTACT URTICARIA; HUMAN; IRRITANT DERMATITIS; NONHUMAN; PHOTOALLERGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SKIN ALLERGY; SKIN TOXICITY; TRANSDERMAL DRUG DELIVERY SYSTEM; VAGINA; VULVA;

EID: 85015578402     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.12.008     Document Type: Review

References (242)

1. 21 USC, 1938 21 USC (1938). Title 21. Federal Food, Drug, and Cosmetic Act, Section 321 et seq. In The United States Code.
2. Ahmad, N., Mukhtar, H., Cytochrome p450: a target for drug development for skin diseases. J. Invest. Dermatol. 123 (2004), 417–425.
3. Ale, I.S., Maibach, H.I., Mechanisms in irritant and allergic contact dermatitis. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 159–167.
4. Alikhan, A., Farahmand, S., Maibach, H.I., Correlating percutaneous absorption with physicochemical parameters in vivo in man: agricultural, steroid, and other organic compounds. J. Appl. Toxicol., 2009.
5. Andersen, K.E., Maibach, H.I., (Eds.) 1985. Contact Allergy Predictive Test in Guinea Pigs S. Karger AG Basel.
6. Auletta, C.S., Current in vivo assays for cutaneous toxicity: local and systemic toxicity testing. Basic Clin. Pharmacol. Toxicol. 95 (2004), 201–208.
7. Barker, N., Hadgraft, J., Rutter, N., Skin permeability in the newborn. J. Invest. Dermatol. 88 (1987), 409–411.
8. Baron, J.M., Holler, D., Schiffer, R., Frankenberg, S., Neis, M., Merk, H.F., Jugert, F.K., Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116 (2001), 541–548.
9. Baron, J.M., Wiederholt, T., Heise, R., Merk, H.F., Bickers, D.R., Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr. Med. Chem. 15 (2008), 2258–2264.
10. Barratt, M.D., A quantitative structure-activity relationship for the eye irritation potential of neutral organic chemicals. Toxicol. Lett. 80 (1995), 69–74.
11. Barratt, M.D., Quantitative structure activity relationships for skin corrosivity of organic acids, bases and phenols. Toxicol. Lett. 75 (1995), 169–176.
12. Barratt, M.D., Integration of QSAR and in vitro toxicology. Environ. Health Perspect. 106:Suppl. 2 (1998), 459–465.
13. Barry, B.W., Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001), 101–114.
14. Basketter, D.A., Gerberick, G.F., Kimber, I., Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem. Toxicol. 39 (2001), 621–627.
15. Basketter, D.A., Evans, P., Fielder, R.J., Gerberick, G.F., Dearman, R.J., Kimber, I., Local lymph node assay - validation, conduct and use in practice. Food Chem. Toxicol. 40 (2002), 593–598.
16. Basketter, D.A., Gerberick, F., Kimber, I., The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermatitis 57 (2007), 70–75.
17. Basketter, D., Cockshott, A., Corsini, E., Gerberick, G.F., Idehara, K., Kimber, I., Van Loveren, H., Matheson, J., Mehling, A., Omori, T., Rovida, C., Sozu, T., Takeyoshi, M., Casati, S., An evaluation of performance standards and non-radioactive endpoints for the local lymph node assay. The report and recommendations of ECVAM Workshop 65. Altern. Lab. Anim. 36 (2008), 243–257.
18. Basketter, D., Darlenski, R., Fluhr, J.W., Skin irritation and sensitization: mechanisms and new approaches for risk assessment. Skin Pharmacol. Physiol. 21 (2008), 191–202.
19. Basketter, D.A., Dearman, R.J., Kimber, I., Gerberick, G.F., Ryan, C.A., The impact of LLNA group size on the identification and potency classification of skin sensitizers: a review of published data. Cutan. Ocul. Toxicol. 28 (2009), 19–22.
20. Behne, M.J., Meyer, J.W., Hanson, K.M., Barry, N.P., Murata, S., Crumrine, D., Clegg, R.W., Gratton, E., Holleran, W.M., Elias, P.M., Mauro, T.M., NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J. Biol. Chem. 277 (2002), 47399–47406.
21. Beltrani, V.S., Occupational dermatoses. Curr. Opin. Allergy Clin. Immunol. 3 (2003), 115–123.
22. Benson, H.A., Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. 2 (2005), 23–33.
23. Berardesca, E., Maibach, H., Racial differences in skin pathophysiology. J. Am. Acad. Dermatol. 34 (1996), 667–672.
24. Berardesca, E., Maibach, H., Ethnic skin: overview of structure and function. J. Am. Acad. Dermatol. 48 (2003), S139–142.
25. Berardesca, E., de Rigal, J., Leveque, J.L., Maibach, H.I., In vivo biophysical characterization of skin physiological differences in races. Dermatologica 182 (1991), 89–93.
26. Berardesca, E., Leveque, J.-L., Maibach, H.I., (eds.) Ethnic skin and hair, 2006, Informa HealthCare, New York.
27. Bernstein, I.A., Vaughan, F.L., Cultured keratinocytes in in vitro dermatotoxicological investigation: a review. J. Toxicol. Environ. Health 2 (1999), 1–30.
28. Blume, U., Ferracin, J., Verschoore, M., Czernielewski, J.M., Schaefer, H., Physiology of the vellus hair follicle: hair growth and sebum excretion. Br. J. Dermatol. 124 (1991), 21–28.
29. Boman, A., Maibach, H.I., Percutaneous absorption of organic solvents. Int. J. Occup. Environ. Health 6 (2000), 93–95.
30. Bos, J.D., Meinardi, M.M., The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9 (2000), 165–169.
31. Botham, P.A., The validation of in vitro methods for skin irritation. Toxicol. Lett. 149 (2004), 387–390.
32. Bouwman, T., Cronin, M.T., Bessems, J.G., van de Sandt, J.J., Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment. Hum. Exp. Toxicol. 27 (2008), 269–276.
33. Bronaugh, R.L., Franz, T.J., Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin. Br. J. Dermatol. 115 (1986), 1–11.
34. Bronaugh, R.L., Maibach, H.I., Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey. J. Invest. Dermatol. 84 (1985), 180–183.
35. Bronaugh, R.L., Maibach, H.I., (eds.) Percutaneous absorption: drugs, cosmetics, mechanisms, methodology, 2005, Marcel Dekker, New York.
36. Bronaugh, R.L., Stewart, R.F., Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J. Pharm. Sci. 74 (1985), 64–67.
37. Bronaugh, R.L., Stewart, R.F., Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin. J. Pharm. Sci. 74 (1985), 1062–1066.
38. Bronaugh, R.L., Weingarten, D.P., Lowe, N.J., Differential rates of percutaneous absorption through the eczematous and normal skin of a monkey. J. Invest. Dermatol. 87 (1986), 451–453.
39. Bronaugh, R.L., Stewart, R.F., Storm, J.E., Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 99 (1989), 534–543.
40. Bucks, D.A., Maibach, H.I., Guy, R.H., Percutaneous absorption of steroids: effect of repeated application. J. Pharm. Sci. 74 (1985), 1337–1339.
41. Buehler, E.V., Delayed Contact Hypersensitivity in the Guinea Pig. Arch. Dermatol. 91 (1965), 171–177.
42. Buehler, E.V., Occlusive patch method for skin sensitization in guinea pigs: the Buehler method. Food Chem. Toxicol. 32 (1994), 97–101.
43. Burdick, A.E., Mathias, C.G., The contact urticaria syndrome. Dermatol. Clin. 3 (1985), 71–84.
44. Cartlidge, P.H.T., Rutter, N., Skin barrier function. Polin, R.A., Fox, W.W., (eds.) Fetal and neonatal physiology, 1991, W.B. Saunders Company, Philadelphia, 569–584.
45. Chew, A.-L., Maibach, H.I., (eds.) Irritant dermatitis, 2006, Springer Publishing Company, Heidelberg.
46. Chiou, Y.B., Blume-Peytavi, U., Stratum corneum maturation. A review of neonatal skin function. Skin Pharmacol. Physiol. 17 (2004), 57–66.
47. Colombo, G., Zucchi, A., Allegra, F., Colombo, P., Zani, F., Santi, P., In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application. Skin Pharmacol. Appl. Skin Physiol. 16 (2003), 130–136.
48. Courtheoux, S., Pechenot, D., Bucks, D.A., Marty, J.P., Maibach, H.I., Wepierre, J., Effect of repeated skin administration on in vivo percutaneous absorption of drugs. Br. J. Dermatol. 115:Suppl 31 (1986), 49–52.
49. Cua, A.B., Wilhelm, K.P., Maibach, H.I., Cutaneous sodium lauryl sulphate irritation potential: age and regional variability. Br. J. Dermatol. 123 (1990), 607–613.
50. Curren, R.D., Harbell, J.W., In vitro alternatives for ocular irritation. Environ. Health Perspect. 106:Suppl 2 (1998), 485–492.
51. Curren, R.D., Harbell, J.W., Ocular safety: a silent (in vitro) success story. Altern. Lab. Anim. 30:Suppl 2 (2002), 69–74.
52. Davila, J.C., Rodriguez, R.J., Melchert, R.B., Acosta, D. Jr., Predictive value of in vitro model systems in toxicology. Annu. Rev. Pharmacol. Toxicol. 38 (1998), 63–96.
53. de Groot, A.C., Bruynzeel, D.P., Bos, J.D., van der Meeren, H.L., van Joost, T., Jagtman, B.A., Weyland, J.W., The allergens in cosmetics. Arch. Dermatol. 124 (1988), 1525–1529.
54. Dean, J.H., Twerdok, L.E., Tice, R.R., Sailstad, D.M., Hattan, D.G., Stokes, W.S., ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul. Toxicol. Pharmacol. 34 (2001), 258–273.
55. Diridollou, S., de Rigal, J., Querleux, B., Leroy, F., Holloway Barbosa, V., Comparative study of the hydration of the stratum corneum between four ethnic groups: influence of age. Int. J. Dermatol. 46:Suppl 1 (2007), 11–14.
56. Draize, J.H., Woodard, G., Calvery, H.O., Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther., 1944, 377–389.
57. ECVAM, 2000. Statement on the Validity of the Local Lymph Node Assay for Skin Sensitization Testing. European Centre for the Validation of Alternative Methods, Joint Research Centre, European Commission.
58. ECVAM, 2008. Murine Local Lymph Node Assay Performance Standards. European Center for the Validation of Alternative Mehtods, Joint Research Centre, European Commission.
59. ECVAM, 2009. European Center for the Validation of Alternative Methods. Institute for Health and Consumer Protection, Joint Research Centre, European Commission, http://ecvam.jrc.it/.
60. Ehling, G., Hecht, M., Heusener, A., Huesler, J., Gamer, A.O., van Loveren, H., Maurer, T., Riecke, K., Ullmann, L., Ulrich, P., Vandebriel, R., Vohr, H.W., An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round. Toxicology 212 (2005), 69–79.
61. Ehling, G., Hecht, M., Heusener, A., Huesler, J., Gamer, A.O., van Loveren, H., Maurer, T., Riecke, K., Ullmann, L., Ulrich, P., Vandebriel, R., Vohr, H.W., An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round. Toxicology 212 (2005), 60–68.
62. Elias, P.M., Brown, B.E., Ziboh, V.A., The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J. Invest. Dermatol. 74 (1980), 230–233.
63. Elias, P.M., Cooper, E.R., Korc, A., Brown, B.E., Percutaneous transport in relation to stratum corneum structure and lipid composition. J. Invest. Dermatol. 76 (1981), 297–301.
64. Fadal, R.G., IgE-mediated hypersensitivity reactions. Otolaryngol. Head Neck Surg. 109 (1993), 565–578.
65. Farage, M., Maibach, H.I., The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures. Contact Dermatitis 51 (2004), 201–209.
66. Farage, M., Maibach, H., Lifetime changes in the vulva and vagina. Arch. Gynecol. Obstet. 273 (2006), 195–202.
67. Farage, M.A., Maibach, H.I., (eds.) The vulva: anatomy, physiology, and pathology, 2006, Informa Healthcare USA, Inc, New York.
68. Farage, M.A., Miller, K.W., Elsner, P., Maibach, H.I., Structural characteristics of the aging skin: a review. Cutan. Ocul. Toxicol. 26 (2007), 343–357.
69. Farage, M.A., Miller, K.W., Elsner, P., Maibach, H.I., Functional and physiological characteristics of the aging skin. Aging Clin. Exp. Res. 20 (2008), 195–200.
70. Farage, M.A., Miller, K.W., Berardesca, E., Maibach, H.I., Clinical implications of aging skin: cutaneous disorders in the elderly. Am. J. Clin. Dermatol. 10 (2009), 73–86.
71. Farage, M.A., Miller, K.W., Maibach, H.I., (eds.) Textbook of aging skin, 2010, Springer, Heidelberg.
72. Farahmand, S., Maibach, H.I., Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach. Int. J. Pharmaceutics 375 (2009), 41–47.
73. Farahmand, S., Maibach, H.I., Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction. Int. J. Pharmaceutics 367 (2009), 1–15.
74. Feldmann, R.J., Maibach, H.I., Regional variation in percutaneous penetration of 14C cortisol in man. J. Invest. Dermatol. 48 (1967), 181–183.
75. Fluhr, J.W., Kao, J., Jain, M., Ahn, S.K., Feingold, K.R., Elias, P.M., Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J. Invest. Dermatol. 117 (2001), 44–51.
76. Fluhr, J.W., Mao-Qiang, M., Brown, B.E., Hachem, J.P., Moskowitz, D.G., Demerjian, M., Haftek, M., Serre, G., Crumrine, D., Mauro, T.M., Elias, P.M., Feingold, K.R., Functional consequences of a neutral pH in neonatal rat stratum corneum. J. Invest. Dermatol. 123 (2004), 140–151.
77. Fenske, N.A., Lober, C.W., Structural and functional changes of normal aging skin. J. Am. Acad. Dermatol. 15 (1986), 571–585.
78. Franz, T.J., Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 64 (1975), 190–195.
79. Freund, J., The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. Am. J. Clin. Pathol. 21 (1951), 645–656.
80. Geinoz, S., Guy, R.H., Testa, B., Carrupt, P.A., Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm. Res. 21 (2004), 83–92.
81. Gerberick, G.F., Ryan, C.A., Kimber, I., Dearman, R.J., Lea, L.J., Basketter, D.A., Local lymph node assay: validation assessment for regulatory purposes. Am. J. Contact Dermat. 11 (2000), 3–18.
82. Gerner, I., Spielmann, H., Hoefer, T., Liebsch, M., Herzler, M., Regulatory use of (Q) SARs in toxicological hazard assessment strategies. SAR and QSAR in environmental research 15 (2004), 359–366.
83. Gerner, I., Liebsch, M., Spielmann, H., Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation. Altern Lab Anim 33 (2005), 215–237.
84. Ghadially, R., Reed, J.T., Elias, P.M., Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol. 107 (1996), 558–564.
85. Gibbs, S., van de Sandt, J.J., Merk, H.F., Lockley, D.J., Pendlington, R.U., Pease, C.K., Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr. Drug Metab. 8 (2007), 758–772.
86. Goldberg, A.M., Maibach, H.I., Dermal toxicity: alternative methods for risk assessment. Environ. Health Perspect. 106:Suppl. 2 (1998), 493–496.
87. Golla, S., Madihally, S., Robinson, R.L. Jr., Gasem, K.A., Quantitative structure-property relationships modeling of skin irritation. Toxicol. In Vitro 23 (2009), 176–184.
88. Gould, A.R., Sharp, P.J., Smith, D.R., Stegink, A.J., Chase, C.J., Kovacs, J.C., Penglis, S., Chatterton, B.E., Bunn, C.L., Increased permeability of psoriatic skin to the protein, plasminogen activator inhibitor 2. Arch. Dermatol. Res. 295 (2003), 249–254.
89. Greaves, M.S., The in vivo catabolism of cortisol of by human skin. J. Invest. Dermatol. 57 (1971), 100–107.
90. Grubauer, G., Feingold, K.R., Harris, R.M., Elias, P.M., Lipid content and lipid type as determinants of the epidermal permeability barrier. J. Lipid Res. 30 (1989), 89–96.
91. Gunathilake, R., Schurer, N.Y., Shoo, B.A., Celli, A., Hachem, J.P., Crumrine, D., Sirimanna, G., Feingold, K.R., Mauro, T.M., Elias, P.M., pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J. Invest. Dermatol. 129 (2009), 1719–1729.
92. Guy, R.H., Hadgraft, J., Bucks, D.A., Transdermal drug delivery and cutaneous metabolism. Xenobiotica; Fate Foreign Compd. Biol. Syst. 17 (1987), 325–343.
93. Haneke, K.E., Tice, R.R., Carson, B.L., Margolin, B.H., Stokes, W.S., ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Regul. Toxicol. Pharmacol. 34 (2001), 274–286.
94. Harpin, V.A., Rutter, N., Barrier properties of the newborn infant's skin. J. Pediatr. 102 (1983), 419–425.
95. Herzler, M., Spielmann, H., Gerner, I., Liebsch, M., Hoefer, T., Use of in vitro data and (Q)SARs to classify eye irritating chemicals in the EU—experience at the BfR. Altex(23 Suppl), 2006, 239–245.
96. Hikima, T., Tojo, K., Maibach, H.I., Skin metabolism in transdermal therapeutic systems. Skin Pharmacol. Physiol. 18 (2005), 153–159.
97. Hoath, S.B., Maibach, H.I., (eds.) Neonatal skin: structure and function, 2003, Marcel Dekker, New York.
98. Hoffmann, S., Saliner, A.G., Patlewicz, G., Eskes, C., Zuang, V., Worth, A.P., A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals. Toxicol. Lett. 180 (2008), 9–20.
99. Hogan, D.J., Maibach, H.I., Adverse dermatologic reactions to transdermal drug delivery systems. J. Am. Acad. Dermatol. 22 (1990), 811–814.
100. Hueber, F., Wepierre, J., Schaefer, H., Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacol. 5 (1992), 99–107.
101. Hueber, F., Besnard, M., Schaefer, H., Wepierre, J., Percutaneous absorption of estradiol and progesterone in normal and appendage-free skin of the hairless rat: lack of importance of nutritional blood flow. Skin Pharmacol. 7 (1994), 245–256.
102. ICCVAM, 1999. The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds, NIH Publication No. 99-4494. Interagency Coordinating Committee on the Validation of Alternative Methods, National Institute of Environmental Health Sciences.
103. ICCVAM, 2009a. Interagency Coordinating Committee on the Validation of Alternative Methods. Established under the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), National Institute of Environmental Health Sciences (NIEHS), http://iccvam.niehs.nih.gov/about/about_ICCVAM.htm.
104. ICCVAM, 2009b. Recommended Performance Standards: Murine Local Lymph Node Assay, NIH Publication Number 09-7357. Interagency Coordinating Committee on the Validation of Alternative Methods (NICEATM), National Institute of Environmental Health Sciences (NIEHS).
105. Jakasa, I., Verberk, M.M., Bunge, A.L., Kruse, J., Kezic, S., Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp. Dermatol. 15 (2006), 801–807.
106. Jakasa, I., Verberk, M.M., Esposito, M., Bos, J.D., Kezic, S., Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J. Invest. Dermatol. 127 (2007), 129–134.
107. Janjua, N.R., Mogensen, B., Andersson, A.M., Petersen, J.H., Henriksen, M., Skakkebaek, N.E., Wulf, H.C., Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J. Invest. Dermatol. 123 (2004), 57–61.
108. Janjua, N.R., Kongshoj, B., Andersson, A.M., Wulf, H.C., Sunscreens in human plasma and urine after repeated whole-body topical application. J. Eur. Acad. Dermatol. Venereol. 22 (2008), 456–461.
109. Jugert, F.K., Agarwal, R., Kuhn, A., Bickers, D.R., Merk, H.F., Mukhtar, H., Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone. J. Invest. Dermatol. 102 (1994), 970–975.
110. Kalia, Y.N., Guy, R.H., Modeling transdermal drug release. Adv. Drug Deliv. Rev. 48 (2001), 159–172.
111. Kao, J., Hall, J., Skin absorption and cutaneous first pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture. J. Pharmacol. Exp. Ther. 241 (1987), 482–487.
112. Kao, J., Carver, M.P., Cutaneous metabolism of xenobiotics. Drug Metab. Rev. 22 (1990), 363–410.
113. Kao, J., Patterson, F.K., Hall, J., Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol. Appl. Pharmacol. 81 (1985), 502–516.
114. Kao, J., Hall, J., Helman, G., In vitro percutaneous absorption in mouse skin: influence of skin appendages. Toxicol. Appl. Pharmacol. 94 (1988), 93–103.
115. Karan, A., Alikhan, A., Maibach, H.I., Toxicologic implications of cutaneous barriers: a molecular, cellular, and anatomical overview. J. Appl. Toxicol. 29 (2009), 551–559.
116. Kartono, F., Maibach, H.I., Irritants in combination with synergistic or additive effect on skin response: overview of tandem irritation studies. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 959–966.
117. Katiyar, S.K., Matsui, M.S., Mukhtar, H., Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol. 114 (2000), 328–333.
118. Kimber, I., Cumberbatch, M., Betts, C.J., Dearman, R.J., Dendritic cells and skin sensitisation hazard assessment. Toxicol. In Vitro 18 (2004), 195–202.
119. Kimber, I., Dearman, R.J., Betts, C.J., Basketter, D.A., Ryan, C.A., Gerberick, F.G., Local lymph node assay. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's Dermatotoxicology, 7th edition, 2008, CRC Press, Boca Raton, 505–515.
120. Klecak, G., The Freund's complete adjuvant test and the open epicutaneous test. A complementary test procedure for realistic assessment of allergenic potential. Andersen, K.E., Maibach, H.I., (eds.) Current problems in dermatology. Contact allergy predictive tests in guinea pigs, 1985, Karger, Basel, 152–171.
121. Klecak, G., Test methods for allergic contact dermatitis in animals. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 443–461.
122. Kligman, A.M., The identification of contact allergens by human assay. I. A critique of standard methods. J. Invest. Dermatol. 47 (1966), 369–374.
123. Kodithala, K., Hopfinger, A.J., Thompson, E.D., Robinson, M.K., Prediction of skin irritation from organic chemicals using membrane-interaction QSAR analysis. Toxicol. Sci. 66 (2002), 336–346.
124. Koeper, L.M., Schulz, A., Ahr, H.J., Vohr, H.W., In vitro differentiation of skin sensitizers by cell signaling pathways. Toxicology 242 (2007), 144–152.
125. Kulkarni, A., Hopfinger, A.J., Osborne, R., Bruner, L.H., Thompson, E.D., Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis. Toxicol. Sci. 59 (2001), 335–345.
126. Lahti, A., Maibach, H.I., An animal model for nonimmunologic contact urticaria. Toxicol. Appl. Pharmacol. 76 (1984), 219–224.
127. Lahti, A., Maibach, H.I., Species specificity of nonimmunologic contact urticaria: guinea pig, rat, and mouse. J. Am. Acad. Dermatol. 13 (1985), 66–69.
128. Lampe, M.A., Burlingame, A.L., Whitney, J., Williams, M.L., Brown, B.E., Roitman, E., Elias, P.M., Human stratum corneum lipids: characterization and regional variations. J. Lipid Res. 24 (1983), 120–130.
129. Lapiere, C.M., The ageing dermis: the main cause for the appearance of ‘old’ skin. Br. J. Dermatol. 122:Suppl 35 (1990), 5–11.
130. Lehman, A.J., Fitzhugh, O.G., 100-fold margin of safety. Assoc. Food Drug Officials U.S. Q. Bull. 18 (1954), 33–35.
131. Leng, G., Leng, A., Kuhn, K.H., Lewalter, J., Pauluhn, J., Human dose-excretion studies with the pyrethroid insecticide cyfluthrin: urinary metabolite profile following inhalation. Xenobiotica; the fate of foreign compounds in biological systems 27 (1997), 1273–1283.
132. Levin, C.Y., Maibach, H.I., Transdermal drug delivery system: an overview. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 2008, CRC Press, Boca Raton, 101–106.
133. Liebsch, M., Spielmann, H., Currently available in vitro methods used in the regulatory toxicology. Toxicol. Lett. 127 (2002), 127–134.
134. Lundov, M.D., Moesby, L., Zachariae, C., Johansen, J.D., Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis 60 (2009), 70–78.
135. Magnusson, B., Kligman, A.M., The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Dermatol. 52 (1969), 268–276.
136. Maguire, H.C.J., Immunoadjuvants in prospective testing for contact allergens. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton.
137. Maguire, H.C.J., Cipriano, D., Split adjuvant technique. Andersen, K.E., Maibach, H.I., (eds.) Current problems in dermatology. Contact allergy predictive tests in guinea pigs, 1985, Karger, Basel, 107–113.
138. Maibach, H., Patrick, E., Dermatoxicology. Hayes, A.W., (eds.) Principles and methods of toxicology, 5th Edition, 2007, Taylor & Francis, Philadelphia, 2270.
139. Maibach, H.I., Johnson, H.L., Contact urticaria syndrome. Contact urticaria to diethyltoluamide (immediate-type hypersensitivity). Arch. Dermatol. 111 (1975), 726–730.
140. Mangelsdorf, S., Otberg, N., Maibach, H.I., Sinkgraven, R., Sterry, W., Lademann, J., Ethnic variation in vellus hair follicle size and distribution. Skin Pharmacol. Physiol. 19 (2006), 159–167.
141. Marzulli, F.N., Maibach, H.I., The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. Food Cosmet. Toxicol. 12 (1974), 219–227.
142. Marzulli, F.N., Maibach, H.I., Relevance of animal models—the hexachlorophene story. Maibach, H.I., (eds.) Animal models in dermatology, 1975, Churchill Living Stone, Edinburgh, 156–167.
143. Marzulli, F.N., Maibach, H.I., (eds.) Dermatotoxicology, 4th Edition, 1991, Hemisphere Publishing Corporation, New York.
144. Marzulli, F.N., Maibach, H.I., Allergic Contact Dermatitis. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's Dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 155–157.
145. Marzulli, F.N., Maibach, H.I., Photoirritation (phototoxicity) testing in humans. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th edition, 2008, CRC Press, Boca Raton, 547–549.
146. Marzulli, F.N., Maibach, H.I., Test Methods for Allergic Contact Dermatitis in Humans. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's Dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 463–467.
147. Mathias, C.G., Contact dermatitis from use or misuse of soaps, detergents, and cleansers in the workplace. Occup. Med. (Philadelphia Pa) 1 (1986), 205–218.
148. Mathias, C.G., Occupational dermatoses. J. Am. Acad. Dermatol. 19 (1988), 1107–1114.
149. Mathias, C.G., J.H., Morrison, Occupational skin diseases, United States. Results from the Bureau of Labor Statistics Annual Survey of Occupational Injuries and Illnesses, 1973 through 1984. Arch. Dermatol. 124 (1988), 1519–1524.
150. Mathias, C.G., Maibach, H.I., Perspectives in occupational dermatology. West. J. Med. 137 (1982), 486–492.
151. Mauro, T., Holleran, W.M., Grayson, S., Gao, W.N., Man, M.Q., Kriehuber, E., Behne, M., Feingold, K.R., Elias, P.M., Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch. Dermatol. Res. 290 (1998), 215–222.
152. Maurer, T., Thomann, P., Weirich, E.G., Hess, R., The optimization test in the guinea-pig. A method for the predictive evaluation of the contact allergenicity of chemicals. Agents Actions 5 (1975), 174–179.
153. McGarry, H.F., The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicology 238 (2007), 71–89.
154. Menczel, E., Maibach, H.I., In vitro human percutaneous penetration of benzyl alcohol and testosterone: epidermal–dermal retention. J. Invest. Dermatol. 54 (1970), 386–394.
155. Merk, H.F., Baron, J.M., Heise, R., Fritsche, E., Schroeder, P., Abel, J., Krutmann, J., Concepts in molecular dermatotoxicology. Exp. Dermatol. 15 (2006), 692–704.
156. Merk, H.F., Baron, J.M., Heise, R., Fritsche, E., Schroeder, P., Abel, J., Krutmann, J., Concepts in Molecular Dermatotoxicology. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's Dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton, 189–199.
157. Merrill, R.A., Regulatory toxicology. Klaassen, C.D., (eds.) Casarett & Doull's toxicology: the basic science of poisons, 2001, McGraw-Hill Companies, The, New York, 1141–1153.
158. Modjtahedi, B.S., Toro, J.R., Engasser, P., Maibach, H.I., Cosmetic reactions. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th Edition, 2008, CRC Press, Boca Raton.
159. Moody, R.P., Chu, I., Dermal exposure to environmental contaminants in the Great Lakes. Environ. Health Perspect. 103:Suppl 9 (1995), 103–114.
160. Moody, R.P., Maibach, H.I., Skin decontamination: Importance of the wash-in effect. Food Chem. Toxicol. 44 (2006), 1783–1788.
161. Moody, R.P., Nadeau, B., Chu, I., In vivo and in vitro dermal absorption of benzo[a]pyrene in rat, guinea pig, human and tissue-cultured skin. J. Dermatol. Sci. 9 (1995), 48–58.
162. Moss, G.P., Dearden, J.C., Patel, H., Cronin, M.T., Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 16 (2002), 299–317.
163. Moulton-Levy, N.M., Maibach, H.I., Photoirritation (phototoxicity, phototoxic dermatitis). Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th edition, 2008, CRC Press, Boca Raton, 209–214.
164. Naisbitt, D.J., Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 194 (2004), 179–196.
165. NAS 1138. Dermal and eye toxicity tests. Principles and procedures for evaluating the toxicity of household substances, 1977, Committee for the Revision of NAS Publication 1138, National Academy of Sciences, Washington, D.C, 41–54.
166. Nielsen, J.B., Percutaneous penetration through slightly damaged skin. Arch. Dermatol. Res. 296 (2005), 560–567.
167. Nielsen, J.B., Nielsen, F., Sorensen, J.A., Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Arch. Dermatol. Res. 299 (2007), 423–431.
168. Ng, K.M., Chu, I., Bronaugh, R.L., Franklin, C.A., Somers, D.A., Percutaneous absorption and metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl) phthalate: comparison of in vitro and in vivo results in the hairless guinea pig. Toxicol. Appl. Pharmacol. 115 (1992), 216–223.
169. Ngo, M.A., O'Malley, M., Maibach, H.I., in press. Percutaneous absorption and exposure assessment of pesticides. J. Appl. Toxicol. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20033883.
170. Nigg, H.N., Stamper, J.H., Biological monitoring for pesticide dose determination. Wang, R.G.M., Franklin, C.A., Honeycutt, R.C., Reinert, J.C., (eds.) Biological monitoring for pesticide exposure: measurement, estimation, and risk reduction, 1989, American Chemical Society, Washington, D.C, 6–27.
171. OECD, 2004. Guidelines for the testing of chemicals: test no. 427: skin absorption: in vivo method. Organization for Economic Cooperation and Development.
172. OECD, 2009. Local Lymph Node Assay (LLNA) Test Guideline 429. Organization for Economic Cooperation and Development.
173. Oesch, F., Fabian, E., Oesch-Bartlomowicz, B., Werner, C., Landsiedel, R., Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab. Rev. 39 (2007), 659–698.
174. Okah, F.A., Wickett, R.R., Pickens, W.L., Hoath, S.B., Surface electrical capacitance as a noninvasive bedside measure of epidermal barrier maturation in the newborn infant. Pediatrics 96 (1995), 688–692.
175. O'Malley, M.A., Mathias, C.G., Distribution of lost-work-time claims for skin disease in California agriculture: 1978-1983. Am. J. Ind. Med. 14 (1988), 715–720.
176. O'Malley, M., Thun, M., Morrison, J., Mathias, C.G., Halperin, W.E., Surveillance of occupational skin disease using the Supplementary Data System. Am. J. Ind. Med. 13 (1988), 291–299.
177. Otberg, N., Richter, H., Schaefer, H., Blume-Peytavi, U., Sterry, W., Lademann, J., Variations of hair follicle size and distribution in different body sites. J. Invest. Dermatol. 122 (2004), 14–19.
178. Patel, H., ten Berge, W., Cronin, M.T., Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 48 (2002), 603–613.
179. Patlewicz, G., Rodford, R., Walker, J.D., Quantitative structure-activity relationships for predicting skin and eye irritation. Environ. Toxicol. Chem./ SETAC 22 (2003), 1862–1869.
180. Patlewicz, G.Y., Basketter, D.A., Pease, C.K., Wilson, K., Wright, Z.M., Roberts, D.W., Bernard, G., Arnau, E.G., Lepoittevin, J.P., Further evaluation of quantitative structure–activity relationship models for the prediction of the skin sensitization potency of selected fragrance allergens. Contact Dermatitis 50 (2004), 91–97.
181. Patlewicz, G., Roberts, D.W., Uriarte, E., A comparison of reactivity schemes for the prediction skin sensitization potential. Chem. Res. Toxicol. 21 (2008), 521–541.
182. Patil, S., Maibach, H.I., Effect of age and sex on the elicitation of irritant contact dermatitis. Contact Dermatitis 30 (1994), 257–264.
183. Peate, W.E., Occupational skin disease. Am. Fam. Physician 66 (2002), 1025–1032.
184. Phillips, L. 2nd, Steinberg, M., Maibach, H.I., Akers, W.A., A comparison of rabbit and human skin response to certain irritants. Toxicol. Appl. Pharmacol. 21 (1972), 369–382.
185. Potts, R.O., Guy, R.H., Predicting skin permeability. Pharm. Res. 9 (1992), 663–669.
186. Potts, R.O., Guy, R.H., A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 12 (1995), 1628–1633.
187. Purdon, C.H., Azzi, C.G., Zhang, J., Smith, E.W., Maibach, H.I., Penetration enhancement of transdermal delivery–current permutations and limitations. Crit. Rev. Ther. Drug Carrier Syst. 21 (2004), 97–132.
188. Ramasastry, P., Downing, D.T., Pochi, P.E., Strauss, J.S., Chemical composition of human skin surface lipids from birth to puberty. J. Invest. Dermatol. 54 (1970), 139–144.
189. REACH, 2006. Registration, Evaluation, Authorisation and Restriction of Chemical substances (REACH). In Regulation (EC) No 1907/2006 of the European Parliament. Environment Directorate General, European Commission, http://ecb.jrc.ec.europa.eu/reach/.
190. Rietschel, R.L., Mathias, C.G., Taylor, J.S., Storrs, F.J., Sherertz, E.F., Pratt, M., Marks, J.G. Jr., Maibach, H.I., Fransway, A.F., Fowler, J.F. Jr., DeLeo, V.A., Belsito, D.V., A preliminary report of the occupation of patients evaluated in patch test clinics. Am. J. Contact Dermat. 12 (2001), 72–76.
191. Rietschel, R.L., Mathias, C.G., Fowler, J.F. Jr., Pratt, M., Taylor, J.S., Sherertz, E.F., Marks, J.G. Jr., Belsito, D.V., Storrs, F.J., Maibach, H.I., Fransway, A.F., Deleo, V.A., Relationship of occupation to contact dermatitis: evaluation in patients tested from 1998 to 2000. Am. J. Contact Dermat. 13 (2002), 170–176.
192. Riviere, J.E., Brooks, J.D., Predicting skin permeability from complex chemical mixtures. Toxicol. Appl. Pharmacol. 208 (2005), 99–110.
193. Riviere, J.E., Baynes, R.E., Brooks, J.D., Yeatts, J.L., Monteiro-Riviere, N.A., Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. J. Toxicol. Environ. Health A 66 (2003), 133–151.
194. Roberts, D.W., Aptula, A.O., Patlewicz, G., Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization. Chemical research in toxicology 19 (2006), 1228–1233.
195. Roberts, D.W., Aptula, A.O., Cronin, M.T., Hulzebos, E., Patlewicz, G., Global (Q)SARs for skin sensitisation: assessment against OECD principles. SAR QSAR Environ. Res. 18 (2007), 343–365.
196. Roberts, D.W., Aptula, A.O., Patlewicz, G., Electrophilic chemistry related to skin sensitization. Reaction mechanistic applicability domain classification for a published data set of 106 chemicals tested in the mouse local lymph node assay. Chem. Res. Toxicol. 20 (2007), 44–60.
197. Rodricks, J.V., Gaylor, D.W., Turnbull, D., Quantitative extrapolations in toxicology. Hayes, A.W., (eds.) Principles and methods of toxicology, 2001, Taylor & Francis, Philadelphia, 365–386.
198. Roskos, K.V., Maibach, H.I., Percutaneous absorption and age. Implications for therapy. Drugs Aging 2 (1992), 432–449.
199. Roskos, K.V., Maibach, H.I., Guy, R.H., The effect of aging on percutaneous absorption in man. J. Pharmacokinet. Biopharm. 17 (1989), 617–630.
200. Rougier, A., Goldberg, A.M., Maibach, H.I., (eds.) In Vitro Skin Toxicology: Irritation, Phototoxicity, Sensitization. Mary Ann Liebert, Inc, 1994, Publishers, New York.
201. Rutter, N., The immature skin. Eur. J. Pediatr. 155:Suppl. 2 (1996), S18–S20.
202. Rutter, N., The dermis. Semin. Neonatol. 5 (2000), 297–302.
203. Sailstad, D.M., Hattan, D., Hill, R.N., Stokes, W.S., ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process. Regul. Toxicol. Pharmacol. 34 (2001), 249–257.
204. Scheuplein, R.J., Blank, I.H., Permeability of the skin. Physiol. Rev. 51 (1971), 702–747.
205. Seko, N., Bando, H., Lim, C.W., Yamashita, F., Hashida, M., Theoretical analysis of the effect of cutaneous metabolism on skin permeation of parabens based on a two-layer skin diffusion/metabolism model. Biological and Pharmaceutical bulletin 22 (1999), 281–287.
206. Shaw, J.E., Prevo, M.E., Amkraut, A.A., Testing of controlled-release transdermal dosage forms. Product development and clinical trials. Arch. Dermatol. 123 (1987), 1548–1556.
207. Smith, E.W., Maibach, H.I., (eds.) Percutaneous penetration enhancers, 2006, CRC Press, Boca Raton.
208. Smith, W.P., Christensen, M.S., Nacht, S., Gans, E.H., Effect of lipids on the aggregation and permeability of human stratum corneum. J. Invest. Dermatol. 78 (1982), 7–11.
209. Smith, E.W., Smith, K.A., Maibach, H.I., Andersson, P.O., Cleary, G., Wilson, D., The local side effects of transdermally absorbed nicotine. Skin Pharmacol. 5 (1992), 69–76.
210. Solomon, A.E., Lowe, N.J., Percutaneous absorption in experimental epidermal disease. Br. J. Dermatol. 100 (1979), 717–722.
211. Spencer, T.S., Hill, J.A., Feldmann, R.J., Maibach, H.I., Evaporation of diethyltoluamide from human skin in vivo and in vitro. J. Invest. Dermatol. 72 (1979), 317–319.
212. Stewart, M.E., Downing, D.T., Measurement of sebum secretion rates in young children. J. Invest. Dermatol. 84 (1985), 59–61.
213. Stewart, M.E., Steele, W.A., Downing, D.T., Changes in the relative amounts of endogenous and exogenous fatty acids in sebaceous lipids during early adolescence. J. Invest. Dermatol. 92 (1989), 371–378.
214. Sweeney, T.M., Downing, D.T., The role of lipids in the epidermal barrier to water diffusion. J. Invest. Dermatol. 55 (1970), 135–140.
215. Thong, H.Y., Zhai, H., Maibach, H.I., Percutaneous penetration enhancers: an overview. Skin Pharmacol. Physiol. 20 (2007), 272–282.
216. Turpeinen, M., Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br. J. Dermatol. 118 (1988), 517–522.
217. Valerio, L.G. Jr., In silico toxicology for the pharmaceutical sciences. Toxicol. Appl. Pharmacol. 241 (2009), 356–370.
218. Valerio, L.G. Jr., Arvidson, K.B., Chanderbhan, R.F., Contrera, J.F., Prediction of rodent carcinogenic potential of naturally occuring chemicals in the human diet using high-throughput QSAR predictive modeling. Toxicology and applied pharmacology 222 (2007), 1–16.
219. van Ravenzwaay, B., Leibold, E., The significance of in vitro rat skin absorption studies to human risk assessment. Toxicol. In Vitro 18 (2004), 219–225.
220. Vinardell, M.P., Mitjans, M., Alternative methods for eye and skin irritation tests: an overview. J. Pharm. Sci. 97 (2008), 46–59.
221. von Krogh, G., Maibach, H.I., The contact urticaria syndrome—an updated review. J. Am. Acad. Dermatol. 5 (1981), 328–342.
222. Wang, X.P., Schunck, M., Kallen, K.J., Neumann, C., Trautwein, C., Rose-John, S., Proksch, E., The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J. Invest. Dermatol. 123 (2004), 124–131.
223. Warshaw, E.M., Schram, S.E., Maibach, H.I., Belsito, D.V., Marks, J.G. Jr., Fowler, J.F. Jr., Rietschel, R.L., Taylor, J.S., Mathias, C.G., DeLeo, V.A., Zug, K.A., Sasseville, D., Storrs, F.J., Pratt, M.D., Occupation-related contact dermatitis in North American health care workers referred for patch testing: cross-sectional data, 1998 to 2004. Dermatitis 19 (2008), 261–274.
224. Wesley, N.O., Maibach, H.I., Racial (ethnic) differences in skin properties: the objective data. Am. J. Clin. Dermatol. 4 (2003), 843–860.
225. West, D.P., Halket, J.M., Harvey, D.R., Hadgraft, J., Solomon, L.M., Harper, J.I., Percutaneous absorption in preterm infants. Pediatr. Dermatol. 4 (1987), 234–237.
226. Wester, R.C., Maibach, H.I., Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab. Rev. 14 (1983), 169–205.
227. Wester, R.C., Maibach, H.I., Bronaugh, R., Maibach, H., (eds.) In Vivo Animal Models for Percutaneous Absorption In Percutaneous Absorption, 1985, Marcel Dekker, New York, 251–266.
228. Wester, R.C., Maibach, H.I., Individual and regional variation with in vitro percutaneous absorption. Bronaugh, R., Maibach, H., (eds.), 1991, CRC Press, Boca Raton, FL, 25–30.
229. Wester, R.C., Maibach, H.I., Understanding percutaneous absorption for occupational health and safety. Int. J. Occup. Environ. Health 6 (2000), 86–92.
230. Wester, R.C., Noonan, P.K., Cole, M.P., Maibach, H.I., Percutaneous absorption of testosterone in the newborn rhesus monkey: comparison to the adult. Pediatr. Res. 11 (1977), 737–739.
231. Wester, R.C., Hui, X., Maibach, H.I., In vivo human transfer of topical bioactive drug between individuals: estradiol. J. Invest. Dermatol. 126 (2006), 2190–2193.
232. Wilhelm, K.-P., Maibach, H.I., OECD guidelines for testing of chemicals. Zhai, H., Wilhelm, K.-P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th edition, 2008, CRC Press, Boca Raton, 303–305.
233. Wilkes, M.F., Woollen, B.H., Marsh, J.R., Batten, P.L., Chester, G., Biological monitoring for pesticide exposure–the role of human volunteer studies. Int. Arch. Occup. Environ. Health 65 (1993), S189–192.
234. Wilkinson, D.S., Patch test reactions to certain halogenated salicylanilides. Br. J. Dermatol. 74 (1962), 302–306.
235. Wilson, D.R., Maibach, H.I., Transepidermal water loss in vivo. Premature and term infants. Biology of the neonate 37 (1980), 180–185.
236. Woollen, B.H., Marsh, J.R., Laird, W.J., Lesser, J.E., The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration. Xenobiotica; the fate of foreign compounds in biological systems 22 (1992), 983–991.
237. Yosipovitch, G., Maayan-Metzger, A., Merlob, P., Sirota, L., Skin barrier properties in different body areas in neonates. Pediatrics 106 (2000), 105–108.
238. Zackheim, H.S., Feldmann, R.J., Lindsay, C., Maibach, H.I., Percutaneous absorption of 1, 3-bis (2-chloroethyl)-I-nitrosourea (BCNU, carmustine) in mycosis fungoides. Br. J. Dermatol. 97 (1977), 65–67.
239. Zendzian, R.P., Dellarco, M., Chapter 18: validating in vitro dermal absorption studies: an introductory case study. Salem, H., Katz, S.A., (eds.) Alternative toxicological methods, 2003, CRC Press, Boca Raton.
240. Zhai, H., Maibach, H.I., Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol. Appl. Skin Physiol. 14 (2001), 1–10.
241. Zhai, H., Wilhelm, K.P., Maibach, H.I., (eds.) Marzulli and Maibach's dermatotoxicology, 7th edition, 2008, CRC Press, Boca Raton.
242. Zhu, Z., Hotchkiss, S.A., Boobis, A.R., Edwards, R.J., Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. Biochem. Biophys. Res. Commun. 297 (2002), 65–70.